Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.82 Analyst target: $11.06 Upside: 129.46%
Savara Inc. is a lung disease orphan company. The company is headquartered in Austin, Texas.
See the full interactive analysis & chart →Informational only — not investment advice.